Old asthma drug may help kids with rare bone disorder
NCT ID NCT04551170
First seen Nov 12, 2025 · Last updated May 20, 2026 · Updated 18 times
Summary
This study tests if theophylline, a drug used for asthma, can help children with pseudohypoparathyroidism, a rare genetic disorder causing obesity and hormone resistance. Researchers will check for weight loss, slower bone growth, and reduced need for other medications. The trial involves 34 children aged 2 to 12 who are obese.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOHYPOPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.